Bret D. Wallace

2.5k total citations · 1 hit paper
17 papers, 1.6k citations indexed

About

Bret D. Wallace is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Bret D. Wallace has authored 17 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Bret D. Wallace's work include Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Bret D. Wallace is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Bret D. Wallace collaborates with scholars based in United States, United Kingdom and South Africa. Bret D. Wallace's co-authors include Matthew R. Redinbo, Sridhar Mani, Hongwei Wang, Jillian Orans, Ja Seol Koo, Li-An Yeh, J. E. Scott, Madhukumar Venkatesh, Christian Jobin and R. Scott Williams and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Molecular Biology.

In The Last Decade

Bret D. Wallace

17 papers receiving 1.6k citations

Hit Papers

Alleviating Cancer Drug Toxicity by Inhibiting a Bacteria... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bret D. Wallace United States 12 1.3k 360 267 222 150 17 1.6k
Jillian Orans United States 12 1.2k 0.9× 315 0.9× 179 0.7× 300 1.4× 138 0.9× 13 1.6k
Lianxiang Luo China 27 1.3k 1.0× 279 0.8× 106 0.4× 175 0.8× 88 0.6× 138 2.5k
Madhukumar Venkatesh United States 12 1.4k 1.1× 446 1.2× 301 1.1× 448 2.0× 345 2.3× 16 2.1k
Silvia Balbo United States 29 1.4k 1.1× 280 0.8× 104 0.4× 70 0.3× 216 1.4× 81 2.4k
Renyi Wu United States 29 1.4k 1.0× 134 0.4× 295 1.1× 114 0.5× 86 0.6× 60 2.2k
Onat Kadioglu Germany 26 1.1k 0.8× 486 1.4× 139 0.5× 209 0.9× 41 0.3× 63 2.0k
Silvia Marín Spain 25 1.2k 1.0× 160 0.4× 166 0.6× 56 0.3× 107 0.7× 88 2.2k
Mohamed E.M. Saeed Germany 28 1.3k 1.0× 498 1.4× 145 0.5× 277 1.2× 33 0.2× 70 2.5k
Genta Kakiyama United States 26 1.3k 1.0× 640 1.8× 273 1.0× 176 0.8× 401 2.7× 64 2.4k
Yanxing Han China 25 813 0.6× 98 0.3× 310 1.2× 204 0.9× 108 0.7× 67 1.8k

Countries citing papers authored by Bret D. Wallace

Since Specialization
Citations

This map shows the geographic impact of Bret D. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bret D. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bret D. Wallace more than expected).

Fields of papers citing papers by Bret D. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bret D. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bret D. Wallace. The network helps show where Bret D. Wallace may publish in the future.

Co-authorship network of co-authors of Bret D. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Bret D. Wallace. A scholar is included among the top collaborators of Bret D. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bret D. Wallace. Bret D. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Challa, Anup P., Xin Hu, Yaqin Zhang, et al.. (2022). Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity. Journal of Chemical Information and Modeling. 62(7). 1783–1793. 9 indexed citations
2.
Williams, Jessica S., Jessica L. Wojtaszek, J.M. Krahn, et al.. (2022). Molecular basis for processing of topoisomerase 1-triggered DNA damage by Apn2/APE2. Cell Reports. 41(1). 111448–111448. 5 indexed citations
3.
Bhatt, Aadra P., Samuel J. Pellock, Kristen A. Biernat, et al.. (2020). Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proceedings of the National Academy of Sciences. 117(13). 7374–7381. 150 indexed citations
4.
Wallace, Bret D., et al.. (2018). Abstract 3985: Identifying and drugging glucuronidase targets in the human gut microbiome. Cancer Research. 78(13_Supplement). 3985–3985. 1 indexed citations
5.
Appel, C. Denise, Geoffrey K. Feld, Bret D. Wallace, & R. Scott Williams. (2016). Structure of the sirtuin‐linked macrodomain SAV0325 from Staphylococcus aureus. Protein Science. 25(9). 1682–1691. 11 indexed citations
6.
Wallace, Bret D., Geoffrey A. Mueller, Sara N. Andres, et al.. (2016). APE2 Zf-GRF facilitates 3′-5′ resection of DNA damage following oxidative stress. Proceedings of the National Academy of Sciences. 114(2). 304–309. 48 indexed citations
7.
Wallace, Bret D. & R. Scott Williams. (2014). Ribonucleotide triggered DNA damage and RNA-DNA damage responses. RNA Biology. 11(11). 1340–1346. 25 indexed citations
8.
Andres, Sara N., Matthew J. Schellenberg, Bret D. Wallace, Percy Tumbale, & R. Scott Williams. (2014). Recognition and repair of chemically heterogeneous structures at DNA ends. Environmental and Molecular Mutagenesis. 56(1). 1–21. 72 indexed citations
9.
Wallace, Bret D., et al.. (2013). Structural and Functional Analysis of the Human Nuclear Xenobiotic Receptor PXR in Complex with RXRα. Journal of Molecular Biology. 425(14). 2561–2577. 46 indexed citations
10.
Roberts, Adam, et al.. (2013). Molecular Insights into Microbial β-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity. Molecular Pharmacology. 84(2). 208–217. 111 indexed citations
11.
Wallace, Bret D. & Matthew R. Redinbo. (2013). The human microbiome is a source of therapeutic drug targets. Current Opinion in Chemical Biology. 17(3). 379–384. 41 indexed citations
12.
Wallace, Bret D. & Matthew R. Redinbo. (2012). Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metabolism Reviews. 45(1). 79–100. 46 indexed citations
13.
Wallace, Bret D., et al.. (2012). Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice. Journal of Pharmacology and Experimental Therapeutics. 341(2). 447–454. 154 indexed citations
15.
Wallace, Bret D., Hongwei Wang, J. E. Scott, et al.. (2010). Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme. Science. 330(6005). 831–835. 811 indexed citations breakdown →
16.
Parsonage, Derek, Gerald L. Newton, Robert C. Holder, et al.. (2010). Characterization of the N-Acetyl-α-d-glucosaminyl l-Malate Synthase and Deacetylase Functions for Bacillithiol Biosynthesis in Bacillus anthracis,. Biochemistry. 49(38). 8398–8414. 48 indexed citations
17.
Degtyareva, Natalya N., et al.. (2006). Hydration Changes Accompanying the Binding of Minor Groove Ligands with DNA. Biophysical Journal. 92(3). 959–965. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026